State Street’s Fibrocell Science Inc. FCSC Stock Holding History

State Street’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-753	Closed	-$8K	–	3681
2016 Q4	$8K	Hold	753	–	–	﹤0.01%	3649
2016 Q3	$8K	Hold	753	–	–	﹤0.01%	3585
2016 Q2	$13K	Sell	753 -18,739	-96%	-$584K	﹤0.01%	3685
2016 Q1	$733K	Buy	19,492 +4,109	+27%	+$164K	﹤0.01%	3282
2015 Q4	$1.05M	Buy	15,383 +2,203	+17%	+$158K	﹤0.01%	3199
2015 Q3	$760K	Buy	13,180 +2,178	+20%	+$193K	﹤0.01%	3259
2015 Q2	$870K	Buy	11,002 +10,329	+1,535%	+$695K	﹤0.01%	3272
2015 Q1	$46K	Hold	673	–	–	﹤0.01%	3589
2014 Q4	$26K	Sell	673 -80	-11%	-$3.23K	﹤0.01%	3633
2014 Q3	$33K	Hold	753	–	–	﹤0.01%	3608
2014 Q2	$45K	Sell	753 -18,545	-96%	-$1.03M	﹤0.01%	3553
2014 Q1	$1.51M	Buy	19,298 +6,157	+47%	+$477K	﹤0.01%	3160
2013 Q4	$800K	Buy	13,141 +2,712	+26%	+$158K	﹤0.01%	3285
2013 Q3	$685K	Buy	10,429 +8,076	+343%	+$653K	﹤0.01%	3312
2013 Q2	$217K	Buy	+2,353	New	+$195K	﹤0.01%	3331

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

State Street's FCSC Position: Q1 2017 in Review

State Street sold out of Fibrocell Science Inc. (FCSC) in Q1 2017, closing a stake of 753 shares — an estimated $8K sold.

State Street first reported a position in FCSC in Q2 2013 and held it in 15 quarters. The position peaked at $1.51M in Q1 2014. 28 funds tracked by Wall St. Rank hold FCSC as of Q1 2017.

State Street reported no remaining Fibrocell Science Inc. position as of Q1 2017 after selling out during the quarter.
State Street sold 753 Fibrocell Science Inc. shares in Q1 2017, an estimated $8K.
State Street first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 15 quarters.
State Street's Fibrocell Science Inc. position peaked at $1.51M in Q1 2014.
28 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2017.

Based on State Street's 13F filing for Q1 2017, filed 15 May 2017.